Share Name Share Symbol Market Type Share ISIN Share Description
Medicx Fund LSE:MXF London Ordinary Share GG00B1DVQL92 ORD NPV
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.75p +0.84% 90.25p 89.50p 90.00p 90.75p 89.25p 90.75p 431,035.00 16:35:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Real Estate Investment & Services 32.8 39.1 9.9 9.1 357.22

Medicx Fund (MXF) Latest News

More Medicx Fund News
Medicx Fund Takeover Rumours

Medicx Fund (MXF) Share Charts

1 Year Medicx Fund Chart

1 Year Medicx Fund Chart

1 Month Medicx Fund Chart

1 Month Medicx Fund Chart

Intraday Medicx Fund Chart

Intraday Medicx Fund Chart

Medicx Fund (MXF) Discussions and Chat

Medicx Fund Forums and Chat

Date Time Title Posts
21/11/201615:27What future for Health Facilities !174.00
19/3/201316:51mxf charts7.00

Add a New Thread

Medicx Fund (MXF) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
16:35:1090.2592,16483,178.01UT
16:29:4090.00374336.60AT
16:29:1190.00348313.20AT
16:29:1190.004641.40AT
16:22:1090.00473425.70AT
View all Medicx Fund trades in real-time

Medicx Fund (MXF) Top Chat Posts

DateSubject
06/12/2016
08:20
Medicx Fund Daily Update: Medicx Fund is listed in the Real Estate Investment & Services sector of the London Stock Exchange with ticker MXF. The last closing price for Medicx Fund was 89.50p.
Medicx Fund has a 4 week average price of 89.13p and a 12 week average price of 88.85p.
The 1 year high share price is 92.75p while the 1 year low share price is currently 80p.
There are currently 395,816,844 shares in issue and the average daily traded volume is 451,020 shares. The market capitalisation of Medicx Fund is £357,224,701.71.
28/7/2016
11:06
ridicule: This share is beginning to pop again. Great yield, but the current share price is well above current NAV. This has kept the share price pegged in the high 80s. People are beginning to understand, however, that NAV will rise as the 15 or so medical centres in their construction phase come on line as rent generators. This is a rock solid high yield investment with further capital gains to come as new medical centres are commissioned.
21/4/2016
08:29
ih_552354: Could be pi's diversifying and taking a 7% yield...+ a little share price increase per annum gives a nice return. V good for an ISA.
10/12/2015
08:57
eeza: Tipped in Telegraph Questor share tip: MedicX offers 7pc dividend income from infrastructure The fund invests in a portfolio of GP surgeries across the country that generate healthy dividends from rental income, says Questor By John Ficenec, Questor Editor - 5:40PM GMT 09 Dec 2015 MedicX 84.75p -0.25p Questor says BUY MedicX [LON:MXF], the infrastructure fund that owns GP surgeries across the UK and Ireland, delivered a solid set of annual results yesterday, with the 7pc dividend looking increasingly attractive. Prior to the formation of the National Health Service in 1948, surgeries largely lacked the facilities their patients needed. Nowadays, GP surgeries are used as the front line of the health service, and only modern, purpose-built facilities will do. MedicX raises the finance for these structures to be built. The company then owns the buildings for their lifetime and earns rent for their use. These rental payments are almost entirely backed by the Government due to the essential role of GP surgeries in the health care system. The debt MedicX uses to finance its portfolio is agreed for 15 years and fixed at a low interest rate of 4.45pc, on average. The company’s investment portfolio increased by 8pc to £559m in the year to the end of September. The rent charged on those buildings rose 9.1pc to £35.8m. MedicX has a conservative 50pc loan-to-value ratio, with net debts of £281m at the end of September. The value of the investment portfolio, minus the debt, gives a net asset value of £258m, or 70.8p per share, at the end of September. MedicX steadily returns cash to investors through quarterly dividend payments, which total 5.9p for the year, or a prospective yield of 7pc given the current 84.25p share price. The shares trade at a 20pc premium to the net asset value but that looks warranted given the steady income and opportunity for growth. Buy. http://tinyurl.com/o9khaqr
09/12/2015
08:05
skinny: Results for the year ended 30 September 2015 Key achievements of 2015 Financial results · 5.4 pence per share increase in EPRA NAV for the year to 70.8 pence per share (30 September 2014: 65.4 pence per share) · Quarterly dividend of 1.475p per share announced in October 20154; total dividends of 5.9p per share for the year or 7.0% dividend yield (2014: total dividends of 5.8p per share; 6.9% dividend yield)4,5 · EPRA earnings of £13.4 million, an increase of £4.7 million or 54% from prior year, equivalent to 3.7p per share (30 September 2014: £8.7 million; 2.5p per share)6 · Dividend and underlying dividend cover 63.3% and 68.0% respectively (30 September 2014: 53.6% and 67.1%)7 · Discounted cash flow net asset value of £346.3 million equivalent to 94.9p per share (30 September 2014: £331.1 million; 93.4p per share) · EPRA NNNAV of £228.9 million equivalent to 62.7p per share (30 September 2014: £229.2 million; 64.7p per share)6 Investments · New committed and approved investments since 1 October 2014 of £41.2 million acquired at a cash yield of 5.78%1 · First investment made in the Republic of Ireland of €10.1 million · £559.5 million committed investment in 148 primary healthcare properties as at 4 December 2015, an increase of 8.0% (8 December 2014): £518.2 million, 137 properties)1,8 · Annualised rent roll at 4 December 2015 of £35.8 million with 88.3% of rents reimbursed by the NHS, an increase of £3.0 million, or 9.1%, since 8 December 20141 · Strong pipeline of approximately £126.0 million of acquisition opportunities1 Funding · Market capitalisation £308.5 million1 following share price appreciation and £6.9 million net proceeds raised from 8.3 million shares issued since 1 October 2014 at an average issue price of 83.1p per share1 · New £50 million loan note with an agreed term of thirteen years and five months with an all-in fixed rate of 3.838% · The maturity on an existing £50 million loan note was extended nine years and three months to mature in December 2028 · Total drawn debt facilities of £338.3 million with an average all-in fixed rate cost of debt of 4.45% and an average unexpired term of 15.0 years, close to average unexpired lease term of the investment properties of 15.8 years and compared with 4.35% and 13.3 years for the prior year · Net debt of £281.4 million equating to 50.2% adjusted gearing at 30 September 2015 (30 September 2014: £255.2 million; 49.9%) more....
22/5/2015
06:06
skinny: Results for the six month period ended 31 March 2015 Highlights Financial results · Total shareholder return of 5.4% for the six month period, of which 1.8% is attributable to share price movements (2014: 8.8%, of which 5.2% is attributable to share price movements)1 · Quarterly dividend of 1.475p per share announced in April 20152; total dividends of 5.9p per share expected for the year or 7.1% dividend yield (2014: total dividends of 5.8p per share; 6.9% dividend yield)3,4 · Dividend cover increased to 67% for the six month period (31 March 2014: 48%)5 · Adjusted earnings of £7.0 million, an increase of £2.3 million or 48.9% from the prior corresponding period, equivalent to 2.0p per share (31 March 2014: £4.7 million; 1.4p per share)6 · Adjusted net asset value of £250.6 million equivalent to 68.8p per share (30 September 2014: £233.1 million; 65.8p per share)6 · Discounted cash flow net asset value of £340.6 million equivalent to 93.5p per share (30 September 2014: £331.1 million; 93.4p per share) Investments · New committed investments between 1 October 2014 and 31 March 2015 of £17.2 million · £535.5 million committed investment in 141 primary healthcare properties, an increase of 3.3% over the period (30 September 2014: £518.3 million, 137 properties)3,7 · Annualised rent roll now £33.9 million with 90% of rents reimbursed by the NHS, an increase of £1.1 million, or 3.4%, since 1 October 20143 · Strong pipeline of approximately £100 million of further acquisition opportunities3 Funding · Market capitalisation £301.5 million3 including £6.8 million net proceeds raised from 8.3 million shares issued since 1 October 2014 at an average issue price of 82.9p per share · New £50 million loan note completed since the period end with an agreed term of thirteen and a half years and an all-in fixed rate of 3.838% · Total drawn debt facilities at 31 March 2015 of £291.5 million with an average all-in fixed rate of debt of 4.52% and an average unexpired term of 14.2 years, close to the average unexpired lease term of the investment properties of 15.6 years and compared with 4.35% and 13.3 years at 30 September 2014 · Net debt of £265.6 million equating to 49.7% adjusted gearing at 31 March 2015
29/5/2013
06:24
goliard: Well it isn't happening, but yesterday's statement from Assura really shows the flaws in MedicX model. Dividend is being paid almost 50% from borrowings and there is a significant manager's fee (unlike Assura). Today's results also shows that the NAV is well below the current share price.
19/2/2011
11:00
grahamg8: Agree goliard it does look like a sleight of hand. But then this is a property company and they are valued on the assets so the share price is properly covered. The mechanism does work with the share price very stable and a dividend yield of 7.6% (5.5p in 2011 against a mid price of 72.5p) that's a massive improvement on money in the bank, and a huge risk premium for the potential day when the institutions shut up shop. Why should they? There is plenty of money sloshing round the City looking for a home. If I were managing a property fund would I buy a house builder, a commercial property company, a construction company, or Medicx? It's MXF for me without a doubt in my ISA as a modest part of an income generating portfolio well diversified by market segments. This will never be earth shattering but gives a regular top up to the bank balance without sleepless nights.
14/10/2009
16:50
selborne_edge: A good point but many of us are long-term investors and waiting just adds to the interest. Not that I think that it will need 50 years for the share price to rise above £1 but 50 weeks would be my guess. The dividends are very reasonable too !
25/3/2009
21:34
selborne_edge: Am I being dense but as the yield is a ratio, it will be subject to any change in the share price. However I would have thought that the dividend amount was fairly safe, based the experience of recent years
Medicx Fund share price data is direct from the London Stock Exchange
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:34 V: D:20161206 19:52:59